Instrument Inactif

Communiqués Lansen Pharmaceutical Holdings Limited

Actions

503 KYG5380M1033

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Lansen Pharmaceutical : FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON 31 MAY 2021	29/04/21	PU
Lansen Pharmaceutical : PROPOSAL FOR RE-ELECTION OF DIRECTORS, GENERAL MANDATES TO ISSUE SHARES, AND REPURCHASE SHARES AND NOTICE OF ANNUAL GENERAL MEETING	29/04/21	PU
Lansen Pharmaceutical : DISPOSAL OF STARRY SHARES	15/04/21	PU
Lansen Pharmaceutical : DISPOSAL OF STARRY SHARES	23/07/20	PU
Lansen Pharmaceutical : CLARIFICATION ANNOUNCEMENT REVISED VOLUNTARY ANNOUNCEMENT IN RESPECT OF THE INFLUENCE OF THE NOVEL CORONAVIRUS	12/02/20	PU
Lansen Pharmaceutical : VOLUNTARY ANNOUNCEMENT IN RESPECT OF THE INFLUENCE OF THE NOVEL CORONAVIRUS	11/02/20	PU
Lansen Pharmaceutical : DISPOSAL OF STARRY SHARES	12/12/19	PU
Lansen Pharmaceutical : RESIGNATION OF NON-EXECUTIVE DIRECTOR AND CHANGE IN COMPOSITION OF REMUNERATION COMMITTEE, AUDIT COMMITTEE AND EXECUTIVE COMMITTEE	31/10/19	PU
Lansen Pharmaceutical : DISPOSAL OF STARRY SHARES	25/09/19	PU
Lansen Pharmaceutical : DISPOSAL OF STARRY SHARES	18/09/19	PU
Lansen Pharmaceutical : VOLUNTARY ANNOUNCEMENT IN RELATION TO FIFTH SHARE REDUCTION PLAN OF STARRY	11/09/19	PU
Lansen Pharmaceutical : DISPOSAL OF STARRY SHARES	10/09/19	PU
Lansen Pharmaceutical : LETTER TO SHAREHOLDERS AND CHANGE REQUEST FORM	10/09/19	PU
Lansen Pharmaceutical : LETTER TO NON-REGISTERED SHAREHOLDERS AND REQUEST FORM	10/09/19	PU
Lansen Pharmaceutical : POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 13 JULY 2016	14/07/16	PU
Lansen Pharmaceutical : FORM OF PROXY FOR USE AT THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON 13 JULY 2016	28/06/16	PU
Lansen Pharmaceutical : CONNECTED AND DISCLOSEABLE TRANSACTION IN RELATION TO THE SECOND TRANCHE SUBSCRIPTION IN HAOTIAN HOLDINGS LIMITED AND CONTINUING CONNECTED AND DISCLOSEABLE TRANSACTION IN RELATION TO THE CROSS GUARA	28/06/16	PU
Lansen Pharmaceutical : NOTICE OF EXTRAORDINARY GENERAL MEETING	28/06/16	PU
Lansen Pharmaceutical : CONNECTED AND DISCLOSABLE TRANSACTION IN RELATION TO THE SECOND TRANCHE SUBSCRIPTION IN HAOTIAN HOLDINGS LIMITED AND CONTINUING CONNECTED AND DISCLOSEABLE TRANSACTION IN RELATION TO THE CROSS GUARANTE	27/06/16	PU
Lansen Pharmaceutical : POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 21 June 2016	23/06/16	PU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Lansen Pharmaceutical Holdings Limited

Actions

503

KYG5380M1033

Communiqués

Filtres